INGREDION INCORPORATED Equity Method Investment, Other than Temporary Impairment
INGREDION INCORPORATED (INGR) reported Equity Method Investment, Other than Temporary Impairment of $2.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-08-07
- INGREDION INCORPORATED equity method investment, other than temporary impairment for the quarter ending 2026-06-30 was $2.00M.
- INGREDION INCORPORATED equity method investment, other than temporary impairment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- INGREDION INCORPORATED equity method investment, other than temporary impairment for the quarter ending 2025-06-30 was -$1.00M, a 105.56% decline year-over-year.
- INGREDION INCORPORATED equity method investment, other than temporary impairment for the quarter ending 2025-03-31 was $5.00M.
- INGREDION INCORPORATED equity method investment, other than temporary impairment for fiscal 2025 was $7.00M, a 61.11% decline from fiscal 2024.
- INGREDION INCORPORATED equity method investment, other than temporary impairment for fiscal 2024 was $18.00M, a 80.00% increase from fiscal 2023.
- INGREDION INCORPORATED equity method investment, other than temporary impairment for fiscal 2023 was $10.00M.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $2.00M 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $7.00M 10-K · filed 2026-02-17 | |||
| 2025-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $4.00M 10-Q · filed 2026-08-07 | $4.00M derived: sum of 3 quarters · filed 2026-08-07 | $4.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $5.00M 10-Q · filed 2026-05-08 | $5.00M derived: sum of 2 quarters · filed 2026-05-08 | $5.00M derived: sum of 3 quarters · filed 2026-05-08 | $23.00M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $18.00M derived: sum of 3 quarters · filed 2026-02-17 | $18.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $18.00M derived: sum of 2 quarters · filed 2025-11-07 | $18.00M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $18.00M 10-K · filed 2025-02-20 | $18.00M 10-Q · filed 2025-08-11 | ||
| 2023-12-31 | $10.00M 10-K · filed 2026-02-17 | |||
| 2023-09-30 | $10.00M 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Post Holdings, Inc. (POST) | United States | $3.260B | 13.64 |
| Freshpet, Inc. (FRPT) | United States | $2.801B | |
| GENERAL MILLS INC (GIS) | United States | $18.629B | -24.78 |